Tara Lipinski Opens Up About Her 'Anxious Dog Mom' Journey and How She Found Peace (Exclusive)
Tara Lipinski admits to PEOPLE she used to be anxious about her dog's health following the death of a past pet
The Olympic gold medalist has found relief by working with a pet care service called Dutch
Lipinski is a mom to her 19-month-old daughter, Georgie, and her flat-coated retriever, SullivanTara Lipinski grew up surrounded by dogs. At one point, her family had five running around the house.
"It was a hoot," the Olympic gold medalist, 42, tells PEOPLE exclusively. "Just us with all these dogs, sometimes traveling to different training centers around the country and bringing them along."
But for Lipinski, her first real dog was Dublin, a brown flat-coated retriever gifted to her by her parents several years ago. So when she revealed in February 2020 that Dublin was battling two aggressive forms of cancer, she was devastated.
As Dublin underwent treatment, Lipinski and her husband, Todd Kapostasy, welcomed Sullivan — "Sully" — another brown flat-coated retriever, into their home. Though the two dogs overlapped for a time, Dublin eventually died. The loss marked the beginning of a deeply emotional journey for Lipinski, which further cemented her identity as a devoted dog mom.
"That was my son," Lipinski says.
"Obviously, we went through a huge medical journey with Dublin, and I've just been very, very conscious of Sullivan's health," she continues. "You can't always prevent something, but I really want to take every precaution and stay on top of everything to make sure he has a long and healthy life."
To do that, Lipinski — also a mom to 19-month-old daughter Georgie — began taking extra precautions, including working with Dutch, an online pet care service. While she still values her longtime vet in Los Angeles, Dutch has offered a different kind of support when she says "life gets busy" and she becomes a "little bit of an anxious dog mom."
That anxiety flared when she recently noticed a bump on Sullivan's tongue.
"Because of everything I went through with Dublin, I immediately thought, 'Oh my goodness, what is this?'" she recalls. "I called the vet but couldn't get in for two weeks because it wasn't an emergency. I was like, 'I don't know how I'm going to sit with this and worry that it's maybe something like Dublin had.'"
"I have spent many nights worrying about something, or the dog's whimpering, or he might've jumped off the bed wrong — and I'm sitting at the vet for six hours while I wait to get my name called," the dog mom adds. "And then I go in and, of course, everything's fine. But still, the process of it all can be difficult."
"I'm sure vets are so in demand with so many emergencies and things that happen, but that's why I really love Dutch. It's given me a lot more control and peace of mind, and I'm also able to tackle things that I probably wouldn't have before."
Never miss a story — sign up for to stay up-to-date on the best of what PEOPLE has to offer, from celebrity news to compelling human interest stories.
With Sullivan's health under control, Lipinski says she can now focus more time and energy on being present with her growing family. Lately, it's been especially rewarding to watch the bond between Sullivan and her daughter Georgie blossom.
"He loves to be part of the bedtime routine," Lipinski says. "He'll cry and scratch at the door if he isn't. He has to be in there — every part of her day. It's like we have a second baby. He needs to sit right at her table when she has breakfast."
"She loves him so much, and he is so gentle. He's so great with her," she adds. "When we do a bath and he's a big 95-pound dog in her little bathroom, he has to be lying right by the tub while we do it. If we're playing with the toys, he's looking — he's in on everything."
"The dropping of the food, too — I think he's in heaven," she continues. "He is like, 'This is what life is meant to be.' Those moments are really cute. He is so big and cuddly, and she's still so small. So to see her curled up next to him and how she says his name with her little baby talk — it warms my heart."
Read the original article on People

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Medscape
40 minutes ago
- Medscape
ASCO 2025: Key Updates in Early Breast Cancer Care
Mariana Chavez MacGregor, MD, MSc, comments on how the ASCO 2025 meeting delivered a wealth of impactful data, particularly in the early-stage breast cancer setting. Trials like neoCARHP and CompassHER2 raised important questions about de-escalating therapy for HER2-positive patients, challenging the role of carboplatin and demonstrating strong pathologic complete response rates with shorter regimens. Long-term data from SOFT and TEXT reinforced the survival benefits of ovarian suppression plus an aromatase inhibitor in high-risk premenopausal patients, and the OASIS 4 study showed promise with elinzanetant in managing vasomotor symptoms. Across subtypes, including triple-negative disease, and with the growing role of AI and circulating tumor DNA, the meeting emphasized more personalized, less toxic approaches to care.


Medscape
40 minutes ago
- Medscape
ASCO 2025: Key Highlights in Advanced Lung Cancer
Just returned from ASCO 2025, Isabel Preeshagul, DO, comments on intriguing data that were presented, including results from REZILIENT1, which showed a 35% response rate for zipalertinib in patients with epidermal growth factor receptor exon 20-altered stage IV non-small cell lung cancer (NSCLC), even those previously treated with targeted therapies, with manageable toxicity. An unexpected finding from another study in the advanced NSCLC space suggested that administering immunochemotherapy before 3:00 PM was associated with better outcomes, possibly due to circadian influences on immune response. In extensive-stage small cell lung cancer, tarlatamab demonstrated superiority over chemotherapy in the DeLLphi-304 trial, with favorable patient-reported outcomes including improved cough and exertional shortness of breath. Finally, Dr Preeshagul notes how the IMforte study reported promising results for maintenance atezolizumab plus lurbinectedin, with improved progression-free survival and overall survival, making it a potential option pending further risk-benefit discussion.


Bloomberg
an hour ago
- Bloomberg
Merck Says It Wins US Approval for Shot to Prevent Infant RSV
Merck & Co. said it won US approval for a shot that protects against RSV, the most common cause of hospitalization among infants. The Food and Drug Administration was considering Merck's preventative for RSV, or respiratory syncytial virus, for children under the age of 1. In clinical trials, Merck's treatment reduced the rate of RSV infection by 60% compared with placebo over five months.